Introspective Market Research (IMR) today announced the release of its Autoimmune Polyglandular Syndrome Type 1 (APS-1) Market Report , projecting a consistent expansion in this rare but clinically significant autoimmune disorder. IMR's analysis estimates that the APS-1 market — recently valued at USD 289.1 million (2025) according to  — will grow to approximately USD 362.8...